20 Recruiting Mycosis Fungoides Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Mycosis Fungoides
Related Conditions
Top Recruiting Mycosis Fungoides Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of VG712 in Patients With Mycosis Fungoides
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
📍 Northwestern University Department of Dermatology — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
📍 Stanford University Medical Center — Stanford, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔